2seventy bio, Inc., headquartered in the United States, is a pioneering biotechnology company focused on developing transformative cell therapies for cancer treatment. Founded in 2020, the company has quickly established itself in the biopharmaceutical industry, particularly in the areas of engineered cell therapies and innovative drug development. With a commitment to advancing the field of oncology, 2seventy bio's core offerings include cutting-edge therapies that harness the power of the immune system to target and eliminate cancer cells. Their unique approach combines scientific expertise with a patient-centric focus, setting them apart in a competitive market. Recognised for its rapid progress and innovative solutions, 2seventy bio is positioned as a leader in the fight against cancer, striving to improve patient outcomes and redefine treatment paradigms.
How does 2seventy bio, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
2seventy bio, Inc.'s score of 45 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
2seventy bio, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of specific emissions data, it is important to note that many companies in the biotechnology sector are increasingly focusing on sustainability and climate commitments. This often includes setting science-based targets for emissions reductions and engaging in initiatives aimed at minimising their carbon footprint. While 2seventy bio, Inc. has not disclosed specific commitments or achievements in this area, the industry trend suggests a growing emphasis on environmental responsibility and climate action.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
2seventy bio, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.